Merck and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.

Enzo Biochem said after the close of markets on Thursday that it has entered an agreement to sell the assets of its clinical laboratory division to Laboratory Corporation of America.

Werfen announced that it has successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals.

Liquid handling instrumentation firm Integra Biosciences said that it has acquired Miroculus, a sample prep automation company that has been developing microfluidics-based platforms for next-generation sequencing.

Spectrum Solutions® announced the acquisitions of Alimetrix, Inc., a CLIA and CAP accredited molecular diagnostic laboratory, and Microarrays, Inc., a leader in customer array-based products that are used as biological research tools.

Beckman Coulter Diagnostics said Tuesday that it has acquired StoCastic, a startup informatics company that develops artificial intelligence-based clinical decision support for hospital emergency departments. Financial terms were not disclosed.

On April 15, 2021, the Wall Street Journal reported that Thermo Fisher, an American medical device giant would acquire PPD, a world-renowned CRO company for $17.4 billion.

A new enzyme biomarker test, developed by Researchers at the Institute for Global Food Security at Queens University Belfast, has the potential to indicate diseases and bacterial contamination. The nanosensor test can detect enzyme markers o